`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`RECKITT BENCKISER
`PHARMACEUTICALS INC., RB
`PHARMACEUTICALS LIMITED, and
`MONOSOL RX, LLC,
`
`Plaintiffs,
`
`Civil Action No. 13-1674-RGA
`
`v.
`
`WATSON LABORATORIES, INC. and
`ACTA VIS LABORATORIES UT, INC.,
`
`Defendants.
`
`RECKITT BENCKISER
`PHARMACEUTICALS INC., RB
`PHARMACEUTICALS LIMITED, and
`MONOSOL RX, LLC,
`
`Plaintiffs,
`
`v.
`
`PAR PHARMACEUTICAL, INC. and
`INTELGENX TECHNOLOGIES CORP.,
`
`Defendants.
`
`Civil Action No. 14-422-RGA
`
`MEMORANDUM ORDER
`
`Presently before the Court is the Motion in Limine of Plaintiffs Reckitt Benckiser
`
`Pharmaceuticals Inc., RB Pharmaceuticals Limited, and MonoSol Rx, LLC to preclude
`
`Defendants Par Pharmaceutical, Inc., IntelGenx Technologies Corp., Watson Laboratories, Inc.,
`
`
`
`Case 1:13-cv-01674-RGA Document 380 Filed 12/16/15 Page 2 of 2 PageID #: 12207
`
`and Actavis Laboratories UT, Inc. from offering at trial evidence concerning inter partes review
`
`of the '832 patent. (D.1. 374-4, 374-5, 374-6). I have also reviewed the parties' responses to my
`
`request at the pretrial conference for certain additional information. (D.1. 376, 377). Plaintiffs'
`
`motion is GRANTED IN PART and DENIED IN PART.
`
`As stated at the pretrial conference, Plaintiffs' motion is GRANTED with respect to the
`
`PTAB's factual findings, decisions, and legal conclusions and DENIED to the extent Defendants
`
`will offer statements of an opposing party admissible under Fed. R. Evid. 801(d)(2). The
`
`remaining part of Plaintiffs' motion concerns documents that would generally fall into the
`
`category of inadmissible hearsay. Unless Defendants have some theory as to why they are
`
`admissible, they should not offer them into evidence. On the specific issue raised at the pretrial
`
`conference concerning the admissibility of the opinion testimony of Defendants' expert Dr. Bley .
`
`that relies on the Reitman Declaration, Plaintiffs' request is DENIED without prejudice. The
`
`question whether "experts in the particular field would reasonably rely on those kinds of facts or
`
`data in forming an opinion on the subject" is a factual question that is not amenable to resolution
`
`at this time. Fed. R. Evid. 703; see Jn re Paoli R.R. Yard PCB Litig., 35 F.3d 717, 748-49 (3d
`
`Cir. 1994). Assuming a sufficient foundation is laid, Dr. Bley may testify regarding opinions
`
`that rely on Dr. Reitman's pH measurement. Plaintiffs should renew at the appropriate time
`
`during trial any objections they want to preserve.
`
`Entered this th- day of December, 2015.
`~&~
`
`2